Prior Auth Required

0027U - analysis exons 12-15

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Serviceanalysis exons 12-15
Procedure / Service Description

Targeted genomic sequence analysis panel, non-small cell lung neoplasia, DNA and RNA - 0026U probability of malignancy" or "Negative, low probability of malignancy") JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, targeted sequence 0027U analysis exons 12-15 CYP2D6 (cytochrome P450, family 2, subfamily D, polypeptide 6) (eg, drug metabolism) gene 0028U analysis, copy number variants, common variants with reflex to targeted sequence analysis

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.